tradingkey.logo
tradingkey.logo
検索

Anbio Biotechnology

NNNN
ウォッチリストに追加
12.700USD
+0.355+2.88%
終値 07/02, 13:00ET15分遅れの株価
557.42M時価総額
86.61直近12ヶ月PER

詳細情報 Anbio Biotechnology 企業名

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnologyの企業情報

企業コードNNNN
会社名Anbio Biotechnology
上場日Feb 19, 2025
最高経営責任者「CEO」Lau (Michael)
従業員数27
証券種類Ordinary Share
決算期末Feb 19
本社所在地Friedrich-Ebert-Anlage 49
都市FRANKFURT AM MAIN
証券取引所NASDAQ OMX - NASDAQ BASIC
Germany
郵便番号60308
電話番号4916096247281
ウェブサイトhttps://anbiobiotechnology.com/
企業コードNNNN
上場日Feb 19, 2025
最高経営責任者「CEO」Lau (Michael)

Anbio Biotechnologyの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

よくある質問

Anbio Biotechnologyの上位5名の株主は誰ですか?

Anbio Biotechnologyの上位5名の株主は以下のとおりです。Mr. Michael Lau

Anbio Biotechnology(NNNN)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Anbio Biotechnologyの株式を保有している機関は13社あり、保有株式の総市場価値は約2.13Mで、全体の4.86%を占めています。2025Q4と比較して、機関の持ち株は2063041.00増加しています。